Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies related to the safety of alpha-cyclodextrin

EFSA Journal

Volumn 5, Issue 8, 2007, Pages

[No Author Info available]

Author keywords

Alpha cyclodextrin; dietary fibre; novel food ingredient

Indexed keywords

EID: 85053459389     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2007.537     Document Type: Article

References (55)

1. Akerblom HK, Koivukangas T, Puukka R, Mononen M (1982). The tolerance of increasing amounts of dietary xylitol in children. Int J Vit Nutr Res 22: 53–56.
2. Andersen GH, Robbins FM, Domingues FJ, Morres RG, Long CL (1963). The utilization of Schardinger dextrins by the rat. Toxicol Appl Pharmacol 5: 257–266.
3. Antenucci RN and Palmer JK (1984). Enzymatic degradation of α- and β-cyclodextrins by Bacteroides of the human colon. J Agric Fd Chem 32: 1316–1321.
4. Bárdos L, Gálné FM, Szente L (1989). Absorption of vitamin A from β-cyclodextrin inclusion complex. Allattenyésztés Takarmányozás 38: 263–268.
5. Bellringer ME, Smith TG, Read R, Gopinath C, Olivier P (1995). B-Cyclodextrin: 52-week toxicity studies in the rat and dog. Fd Chem Toxic 33: 367–376.
6. Blijleven WGH (1991). Examination of alpha-cyclodextrin for mutagenic activity in the Ames test. TNO-Report No. V91.023 of TNO-CIVO Institutes, Zeist, The Netherlands.
7. Connors KA (1995). Population characteristics of cyclodextrin complex stablilities in aqueous solution. J Pharm Sci 84: 843–848.
8. 14C-α-cyclodextrin in rats. TNO-Report No. V93.370 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
9. European Commission (1997). Commission Recommendation 97/618/EC of 29 July 1997 concerning the scientific aspects and the presentation of information necessary to support applications for the placing on the market of novel foods and novel food ingredients and the preparation of initial assessment reports under Regulation (EC) No 258/97 of the European Parliament and of the Council. Official Journal of the European Communities, 16.09.97, L 253/1.
10. Frank DW, Gray JE, Weaver RN (1976). Cyclodextrin nephrosis in the rat. Am J Pathol 35: 367–374.
11. French D (1957). The Schardinger dextrins. Adv Carbohydr Chem 12: 189–260.
12. FSANZ (2004). Food Standards Australia New Zealand. Draft Assessment Report, Application A494, alpha-cyclodextrin as a novel food. www.foodstandards.gov.au/standardsdevelopment/applications/applicationa494alpha2305.cfm
13. Gaebert C and Korff U (2004). Internal report of Consortium fuer Elektrochemische Industrie GmbH. June 4, 2004.
14. Gordon DT, Stoops D, Ratliff V (1995). Dietary fiber and mineral nutrition. In: “Dietary Fiber in Health and Disease”, Kritchevsky D and Bonfield C (eds.). Eagan Press, St. Paul, Minnesota, U.S.A., p. 267–293.
15. Gorman MA and Bowman C (1993). Position of the American Dietetic Association: Health implications of dietary fiber. J Am Dietetic Assoc 93: 1446–1447.
16. GRAS Notice No. 155 (2004) submitted by Wacker Chemical Corporation to the FDA. www.cfsan.fda.gov/~rdb/opa-gn04.html
17. Henderson L, Gregory J, Swan G (2002). The National Diet and Nutrition Survey: adults aged 19 to 64 years. Types and quantities of foods consumed. Her Majesty's Stationery Office. ISBN: 0116215666. London. England.
18. Horiuchi Y, Kikuchi M, Hirayama F, Uekama K, Ueno M, Ijitsu T (1998). Improvement of bioavailability of menaquinone-4 by dimethyl-β-cyclodextrin complexation following oral administration. Yakugaku-Zasshi 108: 1093–1100.
19. Immel HR (1991). Examination of α-cyclodextrin in the micronucleus test. TNO-Report No. V90.435 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
20. Karrer P (1923). Polysaccharide. XX. Zur Kenntnis polymerer Kohlenhydrate. Helv Chim Acta 6: 402–409.
21. Kelsay JL (1990). Effects of fiber on vitamin bioavailability. In: “Dietary Fiber. Chemistry, Physiology, and Health Effects”, Kritchevsky, D. et al. (eds), Plenum Press, New York, p. 129–135.
22. Kondo H, Nakatani H, Hiromi K (1990). In vitro action of human and porcine alpha-amylases on cyclomalto-oligosaccharides. Carbohydr Res 204: 207–213.
23. Lefevre M, Greenway FL, Most MM, Rood JC (2006). General Mills Modified Cereals Efficacy Study. Final Report of 3 February 2006. Pennington Biomedical Research Center, Baton Rouge, U.S.A.
24. Bar L (1992). Subchronic (90-day) oral toxicity study, including a recovery study, with α-cyclodextrin and γ-cyclodextrin in rats. TNO-Report No. V90.401 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
25. Bar L and Bar A (2004a). Subchronic oral toxicity studies with α-cyclodextrin in rats. Regul Toxicol Pharmacol 39: 14–26.
26. Bar L and Bar A (2004b). Subchronic (13-week) oral toxicity study of α-cyclodextrin in dogs. Regul Toxicol Pharmacol 39: 27–33.
27. Marshall JJ and Miwa I (1981). Kinetic difference between hydrolyses of γ-cyclodextrin by human salivary and pancreatic α-amylases. Biochem Biophys Acta 661: 142–147.
28. McCleary BV, Rossiter P, Charnock S, Lloyd R. (2004). Rapid bio-analytical methods – New developments. In: “Dietary fibre: bio-active carbohydrates for food and feed”. J.W. van der Kamp, ed. Wageningen Academic Publishers, Wageningen, The Netherlands, p. 69–81.
29. NTP (1994). Final report on the developmental toxicity of α-cyclodextrin (CAS No. 10016-20-3) in Swiss (CD-1) mice. National Technical Information Service, Springfield, U.S.A. NTIS No. PB94-180781.
30. Price CJ, Navarro HA, Marr MC, Myers CB, Hunter ES, Schwetz, BA (1996). Developmental toxicity evaluation of α-cyclodextrin in mice and rats. Teratology 53: 120 (Abstract P66).
31. Prinsen MK (1991a). Acute eye irritation/corrosion studies with α-cyclodextrin in albino rabbits and ex vivo testing of α-cyclodextrin in the enucleated-eye test with chicken eyes. TNO-Report No. V91.553/210069 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
32. Prinsen MK (1991b). Acute dermal irritation/corrosion study with alpha-cyclodextrin in albino rabbits. TNO-Report No. V91.552/210061 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
33. Prinsen MK (1992). Sensitization study with alpha-cyclodextrin in guinea pigs (maximization test). TNO-Report No. V92.574/352063 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
34. Riebeek WM (1990a). Determination of the acute intravenous toxicity of α-cyclodextrin in mice. TNO-Report No. V90.221 of TNO-CIVO Institutes, Zeist, The Netherlands.
35. Riebeek WM (1990b). Determination of the acute intravenous toxicity of α-cyclodextrin in rats. TNO-Report No. V90.219 of TNO-CIVO Institutes, Zeist, The Netherlands.
36. Rossander L, Sandberg AS, Sandström B (1992). The influence of dietary fiber on mineral absorption and utilization. In: “Dietary Fibre – A component of Food”, Schweizer, T.F. and Edwards, Ch.A. (eds.), Springer-Verlag, London, p. 197–216.
37. Steinke J, Wood FC, Domenge L, Marble A, Renold AE (1961). Evaluation of sorbitol in the diet of diabetic children at camp. Diabetes, 10 (3): 218–227.
38. SCF (Scientific Committee on Food) (2003). Opinion of the Scientific Committee on Food on applications for approval on the Tolerable Upper Intake Level of Vitamin E. Expressed on 4 April 2003. ec.europa.eu/food/fs/sc/scf/out195_en.pdf
39. Stella VJ, Rao VM, Zannou EA, Zia V (1999). Mechanisms of drug release from cyclodextrin complexes. Adv Drug Del Rev 36: 3–16.
40. Szejtly J and Bolla (1980). Stabilisierung fettlöslicher Vitamine mit beta-Cyclodextrin. Starch/Stärke 32: 386–391.
41. Szejtli J, Gerloczy A, Fonagy A (1983). Improvement of the absorption of 3H-Cholecalciferol by formation of its cyclodextrin complex. Pharmazie 38: 100–101.
42. Til HP and van Nesselrooij JHJ (1993). Subchronic (90-day) feeding study with α-cyclodextrin in dogs. TNO-Report No. V92.016 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
43. USDA (1994-96, 1998). Continuing Survey of Food Intakes by Individuals. www.ars.usda.gov/Services/docs.htm?docid=14531
44. 14C]-α-cyclodextrin in rats. TNO-Report No. V94.389 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
45. 14C-α-cyclodextrin in germfree and conventional rats. Regul Toxicol Pharmacol 39: 57–66.
46. Verhagen FJJ and Waalkens-Berendsen DH (1991). Oral embryotoxicity/teratogenicity study with α-cyclodextrin and γ-cyclodextrin in rats. Report No. V91.210 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
47. Von Hoesslin H and Pringsheim H (1923). Zur Physiologie der Polyamylosen. II. Glykogenbildung und tierische Verbrennung. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 131: 168–176.
48. Von Hoesslin H and Pringsheim H (1927). Über die Ernährung von Diabetikern mit Polyamylosen. Münch Med Wschr 74: 95–96.
49. Waalkens-Berendsen DH and Smits-van Prooije AE (1992). Final report of an oral embryotoxicity/teratogenicity study with α-cyclodextrin and γ-cyclodextrin in New Zealand White rabbits. TNO-Report No. V91.564 of TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
50. Waalkens-Berendsen DH and Bär A (2004). Embryotoxicity and teratogenicity study with α-cyclodextrin in rats. Regul. Toxicol. Pharmacol. 39 (Suppl. 1): 34–39.
51. Waalkens-Berendsen DH, Smits-van Prooije AE and Bär A (2004). Embryotoxicity and teratogenicity study with α-cyclodextrin in rabbits. Regul Toxicol Pharmacol 39: 40–46.
52. st meeting of the Joint FAO/WHO, WHO Geneva, WHO Food Additives Series 32: p. 173–193 (β-cyclodextrin).
53. WHO (1996). Toxicological evaluation of certain food additives and contaminants in food. WHO Food Additives Series 35: p. 257–268 (β-cyclodextrin).
54. WHO (2002). Safety evaluation of certain food additives and contaminants. WHO Food Additives Series 48: p. 111–127 (α-cyclodextrin).
55. rd meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 54: 3–15 (α-cyclodextrin).